logo

For the Inventor, By the Inventor

Mannheim, Germany

Boehringer Mannheim Gmbh


USPTO Granted Patents = 1,164


Trademarks = 32

Forward Citations = 40,859

Loading Chart...
Loading Chart...

1,214 inventors (with patents filed for the assignee):

goldMedal Wolfgang Kampe (54 out of 54 patents)

silverMedal Joachim Ziegenhorn (40 out of 40 patents)

bronzeMedal Hans-Georg Batz (37 out of 45 patents)

4.  Walter-Gunar Friebe (36 out of 55 patents)

5.  Max Thiel (35 out of 36 patents)

6.  Elmar Bosies (32 out of 36 patents)

7.  Wolfgang Werner (31 out of 31 patents)

8.  Alfred Mertens (29 out of 33 patents)

9.  Walter Rittersdorf (28 out of 31 patents)

10.  Wolfgang Gruber (28 out of 28 patents)

11.  Kurt Stach (27 out of 27 patents)

12.  Joachim Siedel (26 out of 26 patents)

13.  Wolfgang Schaumann (25 out of 27 patents)

14.  Gisbert Sponer (25 out of 28 patents)

15.  Wolfgang Bartsch (25 out of 25 patents)


Core Competencies:
Biologically Active Substances
Chimeric Serine Proteases
Nucleic Acid Detection
Homogeneous Immunoassay
Thrombolytically Active Proteins
Electrochemical Enzyme Assay
Transdermal Injection Device
Analytical Test Elements
Recombinant Proteins
Nucleic Acid Isolation
Messenger RNA Detection
Lyophilized Pharmaceutical Preparations

1,164 patents:

1. 6689755 - Method of stabilizing biologically active substances (2004-02-10),
2. 6660492 - Chimeric serine proteases (2003-12-09),
3. 6573374 - Nucleotides labelled with an infrared dye and their use in nucleic acid detection (2003-06-03),
4. 6330063 - Low coherence interferometer apparatus (2001-12-11),
5. 6274325 - Method for carrying out a homogeneous-immunoassay based on agglutination (2001-08-14),
6. 6238664 - Process for stabilizing proteins (2001-05-29),
7. 6235279 - Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins (2001-05-22),
8. 6184042 - Method for reducing hook effect in an immunoassay (2001-02-06),
9. 6180948 - Image recording system for evaluating analytical test elements (2001-01-30),
10. 6171842 - Chimeric serine proteases (2001-01-09),
11. 6159722 - Chimeric serine proteases (2000-12-12),
12. 6153192 - Peptides with a characteristic antigenic determinant of (2000-11-28),
13. 6148666 - Method and device for liquid transfer with an analysis apparatus (2000-11-21),
14. 6147199 - 2-deoxy-isoguanosines isoteric analogues and isoguanosine containing (2000-11-14),
15. 6144449 - Low coherence interferometric device (2000-11-07),
Boehringer Mannheim GmbH is a pharmaceutical company based in Mannheim, Germany. Founded in 1885, it specializes in the research, development, and manufacturing of innovative medicines and healthcare solutions. Boehringer Mannheim is renowned for its expertise in areas such as respiratory diseases, immunology, oncology, and central nervous system disorders. With a strong commitment to improving patient lives, the company continuously invests in cutting-edge research and collaborates with global partners to drive advancements in healthcare. For more information, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
1,164 Patents

#1 in G-6800 Mannheim

#43 in Germany

#852 in the World

...
Mannheim, Germany

Boehringer Mannheim Gmbh

Forward Citations = 40,859

1,214 inventors:

goldMedal Wolfgang Kampe (54 out of 54 patents)

silverMedal Joachim Ziegenhorn (40 out of 40 patents)

bronzeMedal Hans-Georg Batz (37 out of 45 patents)

4.  Walter-Gunar Friebe (36 out of 55 patents)

5.  Max Thiel (35 out of 36 patents)

Please report any incorrect information to support@idiyas.com
Loading…